In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
As of close of business last night, Aveanna Healthcare Holdings Inc’s stock clocked out at $8.9, down -2.31% from its previous closing price of $9.11. In other words, the price has decreased by -$2.31 from its previous closing price. On the day, 0.66 million shares were traded. AVAH stock price reached its highest trading level at $9.1399 during the session, while it also had its lowest trading level at $8.79.
Ratios:
To gain a deeper understanding of AVAH’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 12.75 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 24.24. For the most recent quarter (mrq), Quick Ratio is recorded 1.23 and its Current Ratio is at 1.23. In the meantime, Its Debt-to-Equity ratio is 164.49 whereas as Long-Term Debt/Eq ratio is at 143.34.
Upgrades & Downgrades
In the most recent recommendation for this company, BMO Capital Markets on November 13, 2025, initiated with a Outperform rating and assigned the stock a target price of $11.
On September 18, 2025, JP Morgan Upgraded its rating to Neutral which previously was Underweight but kept the price unchanged to $10.
UBS Upgraded its Sell to Neutral on August 19, 2025, while the target price for the stock was maintained at $8.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Oct 24 ’25 when VIGANO PAUL R sold 1,500,000 shares for $9.00 per share. The transaction valued at 13,500,000 led to the insider holds 362,746 shares of the business.
J.H. Whitney Equity Partners V sold 1,251,909 shares of AVAH for $11,267,181 on Oct 24 ’25. The 10% Owner now owns 19,292,787 shares after completing the transaction at $9.00 per share. On Oct 24 ’25, another insider, WILLIAMS ROBERT M JR, who serves as the 10% Owner of the company, sold 1,500,000 shares for $9.00 each. As a result, the insider received 13,500,000 and left with 362,746 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AVAH now has a Market Capitalization of 1859311104 and an Enterprise Value of 3216902400. As of this moment, Aveanna’s Price-to-Earnings (P/E) ratio for their current fiscal year is 24.72, and their Forward P/E ratio for the next fiscal year is 14.26. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.19. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.81 while its Price-to-Book (P/B) ratio in mrq is 202.46. Its current Enterprise Value per Revenue stands at 1.404 whereas that against EBITDA is 12.846.
Stock Price History:
The Beta on a monthly basis for AVAH is 2.05, which has changed by 0.6624087 over the last 52 weeks, in comparison to a change of 0.12415576 over the same period for the S&P500. Over the past 52 weeks, AVAH has reached a high of $10.32, while it has fallen to a 52-week low of $3.67. The 50-Day Moving Average of the stock is -1.71%, while the 200-Day Moving Average is calculated to be 40.62%.
Shares Statistics:
It appears that AVAH traded 1.41M shares on average per day over the past three months and 993600 shares per day over the past ten days. A total of 208.91M shares are outstanding, with a floating share count of 68.97M. Insiders hold about 66.99% of the company’s shares, while institutions hold 25.71% stake in the company. Shares short for AVAH as of 1763078400 were 4452357 with a Short Ratio of 3.17, compared to 1760486400 on 5152755. Therefore, it implies a Short% of Shares Outstanding of 4452357 and a Short% of Float of 6.5.
Earnings Estimates
Investors are keenly observing as 9.0 analysts analyze and rate. The current performance of Aveanna Healthcare Holdings Inc (AVAH) in the stock market.The consensus estimate for the next quarter is $0.13, with high estimates of $0.15 and low estimates of $0.1.
Analysts are recommending an EPS of between $0.59 and $0.52 for the fiscal current year, implying an average EPS of $0.56. EPS for the following year is $0.6, with 10.0 analysts recommending between $0.72 and $0.37.
Revenue Estimates
In. The current quarter, 9 analysts expect revenue to total $622.47M. It ranges from a high estimate of $644.35M to a low estimate of $609M. As of. The current estimate, Aveanna Healthcare Holdings Inc’s year-ago sales were $519.87MFor the next quarter, 9 analysts are estimating revenue of $615.63M. There is a high estimate of $633M for the next quarter, whereas the lowest estimate is $586.8M.
A total of 9 analysts have provided revenue estimates for AVAH’s current fiscal year. The highest revenue estimate was $2.42B, while the lowest revenue estimate was $2.38B, resulting in an average revenue estimate of $2.39B. In the same quarter a year ago, actual revenue was $2.02BBased on 9 analysts’ estimates, the company’s revenue will be $2.57B in the next fiscal year. The high estimate is $2.59B and the low estimate is $2.51B.
